BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Luo SH, Chu JG, Huang H, Yao KC. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases 2019; 7(13): 1599-1610 [PMID: 31367619 DOI: 10.12998/wjcc.v7.i13.1599]
URL: https://www.wjgnet.com/1007-9327/full/v7/i13/1599.htm
Number Citing Articles
1
Z.-X. Chen, Z.-K. Qiu, G.-B. Wang, G.-S. Wang, W.-W. Jiang, F. Gao. Safety and effectiveness of transjugular intrahepatic portosystemic shunt in hepatocellular carcinoma patients with portal hypertension: a systematic review and meta-analysisClinical Radiology 2023; 78(3): 209 doi: 10.1016/j.crad.2022.09.126
2
Blanca Norero, Jaume Bosch, Annalisa Berzigotti, Susana G. Rodrigues. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic reviewUnited European Gastroenterology Journal 2023; 11(8): 733 doi: 10.1002/ueg2.12454
3
Andrea Peloso, Stéphanie Lacotte, Quentin Gex, Florence Slits, Beat Moeckli, Graziano Oldani, Matthieu Tihy, Aurélie Hautefort, Brenda Kwak, Laura Rubbia-Brandt, Christian Toso, Matias A. Avila. Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse modelsPLOS ONE 2023; 18(12): e0296265 doi: 10.1371/journal.pone.0296265
4
Ling Li, Abdala Mkangala, Zhiqi Geng, Wenliang Fan, Yanqiao Ren, Zhongmin Wang, Chuansheng Zheng, Shuping Xiao. Morphine prophylaxis alleviates pain in transjugular intrahepatic portosystemic shunt procedure: A randomized clinical trialTechnology and Health Care 2023; 31(4): 1293 doi: 10.3233/THC-220572
5
Anna Fichtl, Thomas Seufferlein, Eugen Zizer. Risks and benefits of TIPS in HCC and other liver malignancies: a literature reviewBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03047-0
6
Huzheng Yan, Guobao Wang, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang, Fei Gao. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascitesTranslational Oncology 2020; 13(12): 100864 doi: 10.1016/j.tranon.2020.100864
7
Huzheng Yan, Zhenkang Qiu, Zhanwang Xiang, Kai Feng, Mingsheng Huang, Fei Gao. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experienceCancer Imaging 2022; 22(1) doi: 10.1186/s40644-022-00451-9
8
Daniele Balducci, Michele Montori, Federico De Blasio, Alessandro Di Bucchianico, Maria Eva Argenziano, Gianluca Svegliati Baroni, Emidio Scarpellini. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular CarcinomaMedicina 2023; 59(6): 1150 doi: 10.3390/medicina59061150
9
俊池 李. Efficacy and Safety of TACE Combined with TIPS in the Treatment of Hepatocellular Carcinoma Complicated with Portal Hypertension: A Meta-AnalysisAdvances in Clinical Medicine 2024; 14(02): 3840 doi: 10.12677/ACM.2024.142535
10
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo, Xiao Qin. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shuntAbdominal Radiology 2021; 46(11): 5417 doi: 10.1007/s00261-021-03214-5